Vismodegib for the treatment of radiation-induced basal cell carcinoma – a case report and brief literature study
Vismodegib is playing an increasing role in the treatment of locally advanced or metastatic basal cell carcinoma (BCC) that is not a candidate for surgery or radiotherapy, and also in radiation-induced BCC. A 22-year-old man with a history of Hodgkin lymphoma, nodular sclerosis stage IIA, from Octob...
Saved in:
| Main Authors: | Concetta Laliscia, Davide Baldaccini, Andrea Antonuzzo, Fabiola Paiar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2019-12-01
|
| Series: | Contemporary Oncology |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Vismodegib-for-the-treatment-of-radiation-induced-basal-cell-carcinoma-a-case-report-and-brief-literature-study,3,39555,1,1.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Success in the Management of an Extensive Medial Canthal Basal-Cell Carcinoma with Vismodegib
by: Argyrios Tzamalis, et al.
Published: (2024-07-01) -
Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
by: Bingqing Wang, et al.
Published: (2025-05-01) -
Immunohistochemical expression of smoothened in periocular basal cell, squamous cell and sebaceous carcinomas
by: Gustav Stålhammar, et al.
Published: (2025-06-01) -
Use of the Hedgehog signaling pathway inhibitor in the treatment of recurrent locally advanced and metastatic basal cell skin cancer
by: Z. A.-G. Radzhabova, et al.
Published: (2020-02-01) -
Clinical outcomes and adverse events of Hedgehog pathway inhibitors for advanced basal cell carcinoma patients: A systematic review and meta-analysis
by: Suvijak Untaaveesup, et al.
Published: (2025-01-01)